Search Results - Anastasios Stathis

Refine Results
  1. 21
    Incidence, risk factors and outcome of histological transformation in follicular lymphoma

    Incidence, risk factors and outcome of histological transformation in follicular lymphoma by Conconi, Annarita, Ponzio, Carlotta, Lobetti-Bodoni, Chiara, Motta, Maddalena, Rancoita, Paola M.V., Stathis, Anastasios, Moccia, Alden A., Mazzucchelli, Luca, Bertoni, Francesco, Ghielmini, Michele, Cavalli, Franco, Zucca, Emanuele

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 22
    A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors

    A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors by Joerger, Markus, Stathis, Anastasios, Metaxas, Yannis, Hess, Dagmar, Mantiero, Mara, Mark, Michael, Volden, Matthias, Kaindl, Thomas, Engelhardt, Marc, Larger, Patrice, Lane, Heidi, Hafner, Peter, Levy, Nicole, Stuedeli, Silvia, Sessa, Cristiana, von Moos, Roger

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 23
    Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

    Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734 by Spriano, Filippo, Gaudio, Eugenio, Cascione, Luciano, Tarantelli, Chiara, Melle, Federica, Motta, Giovanna, Priebe, Valdemar, Rinaldi, Andrea, Golino, Gaetanina, Mensah, Afua Adjeiwaa, Aresu, Luca, Zucca, Emanuele, Pileri, Stefano, Witcher, Michael, Brown, Bill, Wahlestedt, Claes, Giles, Francis, Stathis, Anastasios, Bertoni, Francesco

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 24
    Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

    Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma by Mensah, Afua A, Cascione, Luciano, Gaudio, Eugenio, Tarantelli, Chiara, Bomben, Riccardo, Bernasconi, Elena, Zito, Domenico, Lampis, Andrea, Hahne, Jens C, Rinaldi, Andrea, Stathis, Anastasios, Zucca, Emanuele, Kwee, Ivo, Gattei, Valter, Valeri, Nicola, Riveiro, Maria E, Bertoni, Francesco

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 25
    New drugs and pharmacological interactions in real life

    New drugs and pharmacological interactions in real life by Stathis, Anastasios

    Published in Hematological oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 26
    Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)

    Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41) by Jackson, Amie E., Mian, Michael, Kalpadakis, Christina, Pangalis, Gerassimos A., Stathis, Anastasios, Porro, Elena, Conconi, Annarita, Cortelazzo, Sergio, Gaidano, Gianluca, Lopez, Armando, Guillermo, Johnson, Peter W., Martelli, Maurizio, Martinelli, Giovanni, Thieblemont, Catherine, McPhail, Ellen D., Copie‐Bergman, Christiane, Pileri, Stefano A., Jack, Andrew, Campo, Elias, Mazzucchelli, Luca, Ristow, Kay, Habermann, Thomas M., Cavalli, Franco, Nowakowski, Grzegorz S., Zucca, Emanuele

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 27
    Prognostic impact of monocyte count at presentation in mantle cell lymphoma

    Prognostic impact of monocyte count at presentation in mantle cell lymphoma by Aprile von Hohenstaufen, Kathrin, Conconi, Annarita, Campos, Cassio Polpo, Franceschetti, Silvia, Bertoni, Francesco, Margiotta Casaluci, Gloria, Stathis, Anastasios, Ghielmini, Michele, Stussi, Georg, Cavalli, Franco, Gaidano, Gianluca, Zucca, Emanuele

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 28
    Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study

    Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study by Mark, Michael, Mora, Alfonso Rojas, Winder, Thomas, Stathis, Anastasios, Jakob, Andreas, Müller, Gisela, Hayoz, Stefanie, Reimann, Patrick, Petrausch, Ulf, von Moos, Roger

    Published in Bone Reports
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  9. 29
    Targeting BET bromodomain proteins in cancer: The example of lymphomas

    Targeting BET bromodomain proteins in cancer: The example of lymphomas by Spriano, Filippo, Stathis, Anastasios, Bertoni, Francesco

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 30
    PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

    PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas by Arribas, Alberto J., Napoli, Sara, Gaudio, Eugenio, Herbaux, Charles, Cannas, Eleonora, Tarantelli, Chiara, Bordone-Pittau, Roberta, Cascione, Luciano, Munz, Nicolas, Aresu, Luca, Sgrignani, Jacopo, Rinaldi, Andrea, Kwee, Ivo, Rossi, Davide, Cavalli, Andrea, Zucca, Emanuele, Stussi, Georg, Stathis, Anastasios, Sloss, Callum, Davids, Matthew S., Bertoni, Francesco

    Published in Blood advances
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  11. 31
    Staining the target: CD37 expression in lymphomas

    Staining the target: CD37 expression in lymphomas by Bertoni, Francesco, Stathis, Anastasios

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  12. 32
    P1132: LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

    P1132: LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA... by Caimi, Paolo F, Ai, Weiyun Z, Pablo Alderuccio, Juan, Ardeshna, Kirit M, Hamadani, Mehdi, Hess, Brian, Kahl, Brad S, Radford, John, Solh, Melhem, Stathis, Anastasios, Luigi Zinzani, Pier, Wang, Ying, Qin, Yajuan, Wang, Luqiang, Xu, Cindy, Carlo‐Stella, Carmelo

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  13. 33
    Identification of Anti-Lymphoma Biomarkers of Response to the Anti-CD37 Antibody Drug Conjugate (ADC) IMGN529

    Identification of Anti-Lymphoma Biomarkers of Response to the Anti-CD37 Antibody Drug Conjugate (ADC) IMGN529 by Gaudio, Eugenio, Tarantelli, Chiara, Arribas, Alberto, Cascione, Luciano, Kwee, Ivo, Rinaldi, Andrea, Ponzoni, Maurilio, Pittau Bordone, Roberta, Stussi, Georg, Rossi, Davide, Zucca, Emanuele, Stathis, Anastasios, Sloss, Callum, Bertoni, Francesco

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  14. 34
    Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma

    Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma by Spriano, Filippo, Sartori, Giulio, Tarantelli, Chiara, Barreca, Marilia, Golino, Gaetanina, Rinaldi, Andrea, Napoli, Sara, Mascia, Michele, Scalise, Lorenzo, Arribas, Alberto J., Cascione, Luciano, Zucca, Emanuele, Stathis, Anastasios, Gaudio, Eugenio, Bertoni, Francesco

    Published in EJHaem
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  15. 35
    A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma

    A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma by Collins, Graham P., Eyre, Toby A., Schmitz‐Rohmer, Debora, Townsend, William, Popat, Rakesh, Giulino‐Roth, Lisa, Fields, Paul A., Krasniqi, Fatime, Soussain, Carole, Stathis, Anastasios, Andjelkovic, Nebojsa, Cunningham, David, Mandic, Danijela, Radulovic, Sinisa, Tijanic, Ivan, Horowitz, Netanel A., Kurtovic, Sabira, Schorb, Elisabeth, Schmidt, Christian, Dimitrijević, Saša, Dreyling, Martin

    Published in HemaSphere
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  16. 36
    An overview on anti-tubulin agents for the treatment of lymphoma patients

    An overview on anti-tubulin agents for the treatment of lymphoma patients by Barreca, Marilia, Stathis, Anastasios, Barraja, Paola, Bertoni, Francesco

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  17. 37
    Genetic alterations in systemic nodal and extranodal non‐cutaneous lymphomas derived from mature T cells and natural killer cells

    Genetic alterations in systemic nodal and extranodal non‐cutaneous lymphomas derived from mature T cells and natural killer cells by Boi, Michela, Stathis, Anastasios, Zucca, Emanuele, Inghirami, Giorgio, Bertoni, Francesco

    Published in Cancer science
    Request full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  18. 38
    The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type

    The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type by Tarantelli, Chiara, Cannas, Eleonora, Ekeh, Hillarie, Moscatello, Carmelo, Gaudio, Eugenio, Cascione, Luciano, Napoli, Sara, Rech, Cesare, Testa, Andrea, Maniaci, Chiara, Rinaldi, Andrea, Zucca, Emanuele, Stathis, Anastasios, Ciulli, Alessio, Bertoni, Francesco

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  19. 39
    Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?

    Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma? by Tarantelli, Chiara, Lupia, Antonio, Stathis, Anastasios, Bertoni, Francesco

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  20. 40
    BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer

    BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer by Genta, Sofia, Pirosa, Maria Cristina, Stathis, Anastasios

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: